Show simple item record

dc.contributor.authorSkinner, Mark W.; orcid: 0000-0002-0934-0680
dc.contributor.authorNugent, Diane
dc.contributor.authorWilton, Pam
dc.contributor.authorO’Mahony, Brian
dc.contributor.authorDolan, Gerry
dc.contributor.authorO’Hara, Jamie
dc.contributor.authorBerntorp, Erik; orcid: 0000-0002-1337-7195
dc.date.accessioned2019-11-23T01:43:38Z
dc.date.available2019-11-23T01:43:38Z
dc.date.issued2019-11-13
dc.identifierdoi: 10.1111/hae.13862
dc.identifier.citationHaemophilia
dc.identifier.urihttp://hdl.handle.net/10034/622839
dc.descriptionFrom Crossref via Jisc Publications Router
dc.descriptionHistory: epub 2019-11-13, issued 2019-11-13
dc.descriptionArticle version: VoR
dc.descriptionFunder: Bayer Pharmaceuticals; Grant(s): NA
dc.publisherWiley
dc.rightsLicence for VoR version of this article starting on 2019-11-13: http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourcepissn: 1351-8216
dc.sourceeissn: 1365-2516
dc.subjectGenetics(clinical)
dc.subjectHematology
dc.subjectGeneral Medicine
dc.titleAchieving the unimaginable: Health equity in haemophilia
dc.typearticle
dc.date.updated2019-11-23T01:43:37Z


This item appears in the following Collection(s)

Show simple item record